INTRODUCTION TO THE KEYNOTE SPEAKER

Date
May 18, 2024

Presenter


Tracks

Related Products

Thumbnail for DNA-HYPOMETHYLATING AGENT DECITABINE COMBINED WITH CAPTEM CHEMOTHERAPY INDUCES REACTIVATION OF TUMOR SUPPRESSOR GENES VIA DOWNREGULATION OF DNMT1 EXPRESSION IN STC-1 NEUROENDOCRINE TUMOR CELLS
DNA-HYPOMETHYLATING AGENT DECITABINE COMBINED WITH CAPTEM CHEMOTHERAPY INDUCES REACTIVATION OF TUMOR SUPPRESSOR GENES VIA DOWNREGULATION OF DNMT1 EXPRESSION IN STC-1 NEUROENDOCRINE TUMOR CELLS
INTRODUCTION: Pancreatic neuroendocrine tumors (PNETs) are a slow-growing, heterogeneous group of neoplasms arising from endocrine tissues of the pancreas. PNETs exhibit a low overall mutational burden, but the genes most commonly mutated are involved in epigenetic regulation…
Thumbnail for RIGHT POSTERIOR BILE DUCT INJURY RECONSTRUCTION WITH ROBOTIC RY HEPATICOJEJUNOSTOMY
RIGHT POSTERIOR BILE DUCT INJURY RECONSTRUCTION WITH ROBOTIC RY HEPATICOJEJUNOSTOMY
Right posterior bile duct injury with disconnected duct syndrome creates diagnostic challenges for many endoscopists and radiologists. The diagnosis and treatment are often delayed…
Thumbnail for EPIGENETIC DYSREGULATION AND IMMUNE CELL INFILTRATION IN THE PANCREATIC NEUROENDOCRINE TUMOR (PNET) MICROENVIRONMENT: AN IMMUNOHISTOCHEMISTRY (IHC) ANALYSIS
EPIGENETIC DYSREGULATION AND IMMUNE CELL INFILTRATION IN THE PANCREATIC NEUROENDOCRINE TUMOR (PNET) MICROENVIRONMENT: AN IMMUNOHISTOCHEMISTRY (IHC) ANALYSIS
BACKGROUND: DNA Methyltransferase inhibitors (DNMTi) have been found to increase the immunogenicity of cancer cells, reshaping the immune tumor microenvironment while directly reprogramming immune cells…